{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:31:24Z","timestamp":1794051084415,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.drudis.2024.103967","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T03:03:03Z","timestamp":1711681383000},"page":"103967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of venom proteomics and single-domain antibodies for antivenoms: Progress in snake envenoming treatment"],"prefix":"10.1016","volume":"29","author":[{"given":"Anna Carolina","family":"Machado Marinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chapeaurouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunheld Maia","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Cibelle S.F.","family":"Quintela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya S.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Freire C.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.103967_b0005","unstructured":"World Health Organization. Snakebite envenoming. World Health Organization. https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/snakebite-envenoming\/snakebite-information-and-data-platform. Published December 04, 2020. Accessed September 25, 2023."},{"key":"10.1016\/j.drudis.2024.103967_b0010","doi-asserted-by":"crossref","first-page":"e0009044","DOI":"10.1371\/journal.pntd.0009044","article-title":"Overview of snakebite in Brazil: possible drivers and a tool for risk mapping","volume":"15","author":"Schneider","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2024.103967_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107033","article-title":"Morbidity survey of the history of snakebites in different communities in the alto Juru\u00e1, western Brazilian Amazon","volume":"224","author":"Rodrigues","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJMra2105228","article-title":"Snake envenomation","volume":"386","author":"Seifert","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2024.103967_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661457","article-title":"Snakebite envenoming diagnosis and diagnostics","volume":"12","author":"Knudsen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2024.103967_b0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40291-021-00533-7","article-title":"Camelid single-domain antibodies for the development of potent diagnosis platforms","volume":"25","author":"Brilhante-da-Silva","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.drudis.2024.103967_b0035","doi-asserted-by":"crossref","first-page":"e0009657","DOI":"10.1371\/journal.pntd.0009657","article-title":"The 20-minute whole blood clotting test (20WBCT) for snakebite coagulopathy-a systematic review and meta-analysis of diagnostic test accuracy","volume":"15","author":"Lamb","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2024.103967_b0040","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/S2214-109X(22)00479-X","article-title":"A global core outcome measurement set for snakebite clinical trials","volume":"11","author":"Abouyannis","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.drudis.2024.103967_b0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijbiomac.2021.06.043","article-title":"Engineering of single-domain antibodies for next-generation snakebite antivenoms","volume":"185","author":"Fernandes","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2024.103967_b0050","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/toxins14110723","article-title":"A review of the proteomic profiling of African Viperidae and Elapidae snake venoms and their antivenom neutralisation","volume":"14","author":"Offor","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00204-022-03420-0","article-title":"A current perspective on snake venom composition and constituent protein families","volume":"97","author":"Tasoulis","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.drudis.2024.103967_b0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2012.09.006","article-title":"Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins","volume":"62","author":"Guti\u00e9rrez","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0065","article-title":"Each phospholipase A2 type exhibits distinct selectivity toward sn-1 ester, alkyl ether, and vinyl ether phospholipids","volume":"1867","author":"Hayashi","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"10.1016\/j.drudis.2024.103967_b0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/mcp.M700094-MCP200","article-title":"Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia)","volume":"7","author":"Fry","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2024.103967_b0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.toxicon.2003.11.002","article-title":"Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes","volume":"42","author":"Kini","year":"2003","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.drudis.2024.103967_b0080","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1021\/acs.jmedchem.3c00097","article-title":"Catalytically active snake venom PLA2 enzymes: an overview of its elusive mechanisms of reaction","volume":"66","author":"Castro-Amorim","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.103967_b0085","series-title":"Toxins and Drug Discovery: Toxinology","first-page":"129","article-title":"Antiproliferative effects of snake venom phospholipases A2 and their perspectives for cancer treatment","author":"Osipov","year":"2017"},{"key":"10.1016\/j.drudis.2024.103967_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40409-018-0170-y","article-title":"Cytotoxic and inflammatory potential of a phospholipase A2 from Bothrops jararaca snake venom","volume":"24","author":"Cedro","year":"2018","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.drudis.2024.103967_b0095","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1107\/S0907444913018003","article-title":"Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus","volume":"69","author":"Coronado","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.drudis.2024.103967_b0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2795(75)90139-7","article-title":"Studies of an acidic cardiotoxin isolated from the venom of mojave rattlesnake (Crotalus scutulatus)","volume":"400","author":"Bieber","year":"1975","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2024.103967_b0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.toxicon.2010.07.010","article-title":"Structure, function and evolution of three-finger toxins: mini proteins with multiple targets","volume":"56","author":"Kini","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2020.100052","article-title":"Snake venom metalloproteinases (SVMPs): a structure-function update","volume":"7","author":"Olaoba","year":"2020","journal-title":"Toxicon X"},{"key":"10.1016\/j.drudis.2024.103967_b0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbapap.2011.04.009","article-title":"Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM\/ADAMTS family proteins","volume":"1824","author":"Takeda","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2024.103967_b0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/toxins8040093","article-title":"Hemorrhage caused by snake venom metalloproteinases: a journey of discovery and understanding","volume":"8","author":"Guti\u00e9rrez","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.toxicon.2005.02.029","article-title":"Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage","volume":"45","author":"Guti\u00e9rrez","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0969-2126(98)00119-1","article-title":"The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases","volume":"6","author":"Parry","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.drudis.2024.103967_b0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.toxicon.2005.02.020","article-title":"Snake venom serine proteinases: sequence homology vs. substrate specificity, a paradox to be solved","volume":"45","author":"Serrano","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/toxins12060358","article-title":"The procoagulant snake venom serine protease potentially having a dual, blood coagulation factor V and X-activating activity","volume":"12","author":"Latinovi\u0107","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"17","key":"10.1016\/j.drudis.2024.103967_b0145","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/0929867324666170605091546","article-title":"Snake venom: from deadly toxins to life-saving therapeutics","volume":"24","author":"Waheed","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2024.103967_b0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.taap.2018.08.018","article-title":"BjSP, a novel serine protease from Bothrops jararaca snake venom that degrades fibrinogen without forming fibrin clots","volume":"357","author":"Carone","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.drudis.2024.103967_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114105","article-title":"Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases","volume":"181","author":"Kini","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2024.103967_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114168","article-title":"Snake three-finger \u03b1-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine","volume":"181","author":"Nirthanan","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2024.103967_b0165","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.3390\/ijms24032919","article-title":"What are the neurotoxins in hemotoxic snake venoms?","volume":"24","author":"Osipov","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.103967_b0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/toxins10090373","article-title":"Proteomic deep mining the venom of the red-headed krait, Bungarus flaviceps","volume":"10","author":"Chapeaurouge","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/toxins12030175","article-title":"Cysteine-rich secretory proteins (CRISPs) from venomous snakes: an overview of the functional diversity in a large and underappreciated superfamily","volume":"12","author":"Tadokoro","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbpc.2009.03.002","article-title":"Purification and characterization of a cysteine-rich secretory protein from Philodryas patagoniensis snake venom","volume":"150","author":"Peichoto","year":"2009","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.drudis.2024.103967_b0185","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-009-0050-2","article-title":"Protein complexes in snake venom","volume":"66","author":"Doley","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"3\u20136","key":"10.1016\/j.drudis.2024.103967_b0190","first-page":"148","article-title":"Multifunctional snake C-type lectins affecting platelets","volume":"31","author":"Clemetson","year":"2001","journal-title":"Haemostasis"},{"key":"10.1016\/j.drudis.2024.103967_b0195","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0021-9258(18)52246-8","article-title":"Complete primary structure of a galactose-specific lectin from the venom of the rattlesnake Crotalus atrox. Homologies with Ca2+-dependent-type lectins","volume":"266","author":"Hirabayashi","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.103967_b0200","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1021\/bi035871a","article-title":"X-ray crystal structure of a galactose-specific C-type lectin possessing a novel decameric quaternary structure","volume":"43","author":"Walker","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2024.103967_b0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.toxicon.2020.06.010","article-title":"Targeted identification of C-type lectins in snake venom by 2DE and Western blot","volume":"185","author":"Ning","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/196754","article-title":"Snake venom L-amino acid oxidases: trends in pharmacology and biochemistry","volume":"2014","author":"Izidoro","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2024.103967_b0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/oxfordjournals.jbchem.a022287","article-title":"Comparison of the apoptotic pathways induced by L-amino acid oxidase and hydrogen peroxide","volume":"125","author":"Suhr","year":"1999","journal-title":"J Biochem"},{"key":"10.1016\/j.drudis.2024.103967_b0220","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/bi992416z","article-title":"Molecular cloning and functional analysis of apoxin I, a snake venom-derived apoptosis-inducing factor with L-amino acid oxidase activity","volume":"39","author":"Torii","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2024.103967_b0225","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1046\/j.1432-1327.2001.02321.x","article-title":"Structure and characterization of the glycan moiety of L-amino-acid oxidase from the Malayan pit viper Calloselasma rhodostoma","volume":"268","author":"Geyer","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.drudis.2024.103967_b0230","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1074\/mcp.M115.056523","article-title":"Mapping proteoforms and protein complexes from king cobra venom using both denaturing and native top-down proteomics","volume":"15","author":"Melani","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.drudis.2024.103967_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/2748962","article-title":"Anti-metalloprotease P-I single-domain antibodies: tools for next-generation snakebite antivenoms","volume":"2022","author":"Silva","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2024.103967_b0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxicon.2018.01.015","article-title":"L-amino acid oxidase from snake venom and its anticancer potential","volume":"144","author":"Tan","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0245","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/BST20200110","article-title":"Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and L-amino acid oxidase","volume":"48","author":"Hiu","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.drudis.2024.103967_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/675985","article-title":"State of the art in the studies on crotamine, a cell penetrating peptide from South American rattlesnake","volume":"2014","author":"Kerkis","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2024.103967_b0255","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1046\/j.1432-1033.2003.03563.x","article-title":"Solution structure of crotamine, a Na+ channel affecting toxin from Crotalus durissus terrificus venom","volume":"270","author":"Nicastro","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.drudis.2024.103967_b0260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0005-2795(78)90457-9","article-title":"Chemical and functional homology of myotoxin a from prairie rattlesnake venom and crotamine from South American rattlesnake venom","volume":"532","author":"Cameron","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2024.103967_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.03.007","article-title":"Mechanistic insights into functional characteristics of native crotamine","volume":"146","author":"Batista da Cunha","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00726-017-2513-3","article-title":"Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile","volume":"50","author":"Campeiro","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.drudis.2024.103967_b0275","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.toxicon.2006.07.005","article-title":"Distribution of 125I-labeled crotamine in mice tissues","volume":"48","author":"Boni-Mitake","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.toxicon.2008.06.029","article-title":"Cytotoxic effects of crotamine are mediated through lysosomal membrane permeabilization","volume":"52","author":"Hayashi","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0285","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0290","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41570-022-00393-7","article-title":"The chemistry of snake venom and its medicinal potential","volume":"6","author":"Oliveira","year":"2022","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.drudis.2024.103967_b0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jprot.2009.01.020","article-title":"Antidotes against venomous animals: state of the art and prospectives","volume":"72","author":"Espino-Solis","year":"2009","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.103967_b0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/S0104-79301999000200002","article-title":"The improvement and standardization of antivenom production in developing countries: comparing antivenom quality, therapeutical efficiency, and cost","volume":"5","author":"Krifi","year":"1999","journal-title":"J Venom Anim Toxins"},{"key":"10.1016\/j.drudis.2024.103967_b0305","first-page":"47","article-title":"Upon the mechanism of the neutralization of cobra venom by its antitoxin","volume":"21","author":"Calmette","year":"1909","journal-title":"J Med Res"},{"key":"10.1016\/j.drudis.2024.103967_b0310","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj0730119","article-title":"The hydrolysis of rabbit \u03b3-globulin and antibodies with crystalline papain","volume":"73","author":"Porter","year":"1959","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2024.103967_b0315","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2024.103967_b0320","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/toxins11010005","article-title":"Global availability of antivenoms: the relevance of public manufacturing laboratories","volume":"11","author":"Guti\u00e9rrez","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0325","doi-asserted-by":"crossref","first-page":"e0009469","DOI":"10.1371\/journal.pntd.0009469","article-title":"Appraisal of antivenom production in public laboratories in Latin America during the first semester of 2020: the impact of COVID-19","volume":"15","author":"Guti\u00e9rrez","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2024.103967_b0330","doi-asserted-by":"crossref","first-page":"e0007059","DOI":"10.1371\/journal.pntd.0007059","article-title":"Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming","volume":"13","author":"Williams","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2024.103967_b0335","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.bbagen.2018.08.019","article-title":"Nanobodies as novel therapeutic agents in envenomation","volume":"1862","author":"Alirahimi","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.drudis.2024.103967_b0340","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/toxins10120534","article-title":"Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims","volume":"10","author":"Kini","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0345","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/dta.3108","article-title":"The application of laboratory-based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation","volume":"13","author":"Patra","year":"2021","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.drudis.2024.103967_b0350","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/toxins14090606","article-title":"Antibodies as snakebite antivenoms: past and future","volume":"14","author":"Dias da Silva","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124478","article-title":"Recent advancements in snake antivenom production","volume":"240","author":"Rathore","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2024.103967_b0360","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbagen.2006.04.008","article-title":"Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom","volume":"1760","author":"Tamarozzi","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2024.103967_b0365","unstructured":"Dempsey DT, Roy D, Capovilla A. Composition and methods for treating snake envenomation. Patent of United States US20200157197A1. https:\/\/patents.google.com\/patent\/US20200157197A1\/en. Published May 21, 2020. Accessed December 27, 2023."},{"key":"10.1016\/j.drudis.2024.103967_b0370","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.molimm.2009.03.002","article-title":"Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3","volume":"46","author":"Groot","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.drudis.2024.103967_b0375","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.103967_b0380","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","article-title":"Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains","volume":"7","author":"Muyldermans","year":"1994","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.drudis.2024.103967_b0385","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-1759(99)00138-6","article-title":"Single domain antibodies: comparison of camel VH and camelised human VH domains","volume":"231","author":"Riechmann","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.drudis.2024.103967_b0390","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.drudis.2024.103967_b0395","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1517\/14712598.5.1.111","article-title":"Nanobodies as novel agents for cancer therapy","volume":"5","author":"Revets","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.drudis.2024.103967_b0400","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2024.103967_b0405","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1093\/emboj\/17.13.3512","article-title":"Potent enzyme inhibitors derived from dromedary heavy-chain antibodies","volume":"17","author":"Lauwereys","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2024.103967_b0410","doi-asserted-by":"crossref","first-page":"e0151363","DOI":"10.1371\/journal.pone.0151363","article-title":"Inhibition of the myotoxicity induced by Bothrops jararacussu venom and isolated phospholipases A2 by specific camelid single-domain antibody fragments","volume":"11","author":"Prado","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.103967_b0415","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/toxins10040142","article-title":"Camelid single-domain antibodies (VHHs) against crotoxin: a basis for developing modular building blocks for the enhancement of treatment or diagnosis of crotalic envenoming","volume":"10","author":"Luiz","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.drudis.2024.103967_b0420","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.jprot.2012.01.020","article-title":"Exploring the proteomes of the venoms of the Peruvian pit vipers Bothrops atrox, B. barnetti and B. pictus","volume":"75","author":"Kohlhoff","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.103967_b0425","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fimmu.2020.00655","article-title":"Development of nanobodies against hemorrhagic and myotoxic components of Bothrops atrox snake venom","volume":"11","author":"Bailon Calderon","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2024.103967_b0430","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0300-9084(00)01163-9","article-title":"Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage","volume":"82","author":"Guti\u00e9rrez","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.drudis.2024.103967_b0435","doi-asserted-by":"crossref","first-page":"e69495","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of \u03b1-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.103967_b0440","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2024.103967_b0445","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14789450.2020.1778471","article-title":"Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research","volume":"17","author":"Chanda","year":"2020","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.drudis.2024.103967_b0450","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jprot.2016.02.006","article-title":"Integrative characterization of the venom of the coral snake Micrurus dumerilii (Elapidae) from Colombia: proteome, toxicity, and cross-neutralization by antivenom","volume":"136","author":"Rey-Su\u00e1rez","year":"2016","journal-title":"J Proteomics"},{"key":"10.1016\/j.drudis.2024.103967_b0455","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cels.2021.01.003","article-title":"Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies","volume":"12","author":"Xiang","year":"2021","journal-title":"Cell Syst"},{"key":"10.1016\/j.drudis.2024.103967_b0460","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.1100116","article-title":"Analysis and modeling of the variable region of camelid single-domain antibodies","volume":"186","author":"Sircar","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2024.103967_b0465","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2015.03.012","article-title":"Getting to the core of protein pharmaceuticals \u2013comprehensive structure analysis by mass spectrometry","volume":"93","author":"Leurs","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.drudis.2024.103967_b0470","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1039\/D2SC01536F","article-title":"Mapping paratopes of nanobodies using native mass spectrometry and ultraviolet photodissociation","volume":"13","author":"Macias","year":"2022","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2024.103967_b0475","article-title":"Serum proteomics expands on high-affinity antibodies in immunized rabbits than deep B-cell repertoire sequencing alone","author":"Bonissone","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2024.103967_b0480","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nmeth.3170","article-title":"A robust pipeline for rapid production of versatile nanobody repertoires","volume":"11","author":"Fridy","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2024.103967_b0485","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/febs.15515","article-title":"A guide to: generation and design of nanobodies","volume":"288","author":"Muyldermans","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.drudis.2024.103967_b0490","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.drudis.2022.05.002","article-title":"Advances in antibody phage display technology","volume":"27","author":"Ledsgaard","year":"2022","journal-title":"Drug Discov Today"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:54:17Z","timestamp":1714517657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1359644624000928"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103967","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of venom proteomics and single-domain antibodies for antivenoms: Progress in snake envenoming treatment","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103967"}}